HW
TEVA icon

Hamilton Wealth’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Hamilton Wealth’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,209
Closed -$274K – 122
2024
Q3 		$274K Buy
15,209
+4,492
+42% +$78.6K 0.07% 82
2024
Q2 		$174K Buy
+10,717
New +$165K 0.05% 96

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Hamilton Wealth's TEVA Position: Q4 2024 in Review

Hamilton Wealth sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2024, closing a stake of 15,209 shares — an estimated $274K sold.

Hamilton Wealth first reported a position in TEVA in Q2 2024 and held it in 2 quarters. The position peaked at $274K in Q3 2024. 584 funds tracked by Wall St. Rank hold TEVA as of Q4 2024.

  • Hamilton Wealth reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2024 after selling out during the quarter.
  • Hamilton Wealth sold 15,209 Teva Pharmaceutical Industries Limited shares in Q4 2024, an estimated $274K.
  • Hamilton Wealth first reported a position in Teva Pharmaceutical Industries Limited in Q2 2024 and held it in 2 quarters.
  • Hamilton Wealth's Teva Pharmaceutical Industries Limited position peaked at $274K in Q3 2024.
  • 584 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2024.

Based on Hamilton Wealth's 13F filing for Q4 2024, filed 14 Nov 2025.